Weight Loss in Patients with Dementia: Considering the Potential Impact of Pharmacotherapy
| Autor: | Amanda J. Kiliaan, Bart A. A. Franx, Deborah R. Gustafson, Ilse A.C. Arnoldussen |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Alzheimer`s disease Donders Center for Medical Neuroscience [Radboudumc 1] Drug-Related Side Effects and Adverse Reactions MEDLINE Article Body Mass Index 03 medical and health sciences 0302 clinical medicine Pharmacotherapy Weight loss Weight Loss mental disorders Life Science Humans Medicine Dementia Pharmacology (medical) In patient 030212 general & internal medicine Psychiatry business.industry Cognition medicine.disease Geriatrics and Gerontology medicine.symptom Cognition Disorders business Body mass index 030217 neurology & neurosurgery Biomedical sciences |
| Zdroj: | Drugs & Aging, 34, 425-436 Drugs and Aging, 34(6), 425-436 Drugs & Aging, 34, 6, pp. 425-436 Drugs and Aging 34 (2017) 6 |
| ISSN: | 1179-1969 1170-229X |
| Popis: | Item does not contain fulltext Unintentional body weight loss is common in patients with dementia and is linked to cognitive impairment and poorer disease outcomes. It is proposed that some dementia medications with market approval, while aiming to improve cognitive and functional outcomes of a patient with dementia, are associated with reported body weight or body mass index loss. This review presents evidence in the published literature on body weight loss in dementia, describes selected theories behind body weight loss, evaluates the potential impact of approved dementia pharmacotherapies on body weight, considers the potential role for medical foods, understands the potential influence of treatments for neuropsychiatric symptoms and signs, and finally, summarizes this important area. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink